Phosphodiesterase inhibitors: knockout drops?
Raeburn
D
D
Rhône-Poulenc Rorer Ltd, Dagenham Research Centre, Essex, UK.
Karlsson
J A
JA
D000818:Animals; D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D016535:Bronchial Hyperreactivity / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors*; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use
D018927:Anti-Asthmatic Agents; D007527:Isoenzymes; D010726:Phosphodiesterase Inhibitors